Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-09-14

Clinical Trial Update: Efficacy and Tolerability of Baclofen for Alcohol Dependence [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 trial results assess the efficacy and tolerability of baclofen for alcohol use disorder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LIORESAL (BACLOFEN)

Snippet

Sponsor: University of North Carolina, Chapel Hill | Conditions: Alcohol Dependence | Phase 2, Phase 3 | Status: COMPLETED